Get a CA-125 (Ovarian Tumour Marker) blood test at VRX Diagno Lounge, Goregaon West — used in women with suspected ovarian cancer, post-treatment monitoring, and evaluation of pelvic masses. Best interpreted alongside pelvic ultrasound and clinical assessment. Pathologist-reviewed report. 24×7 home collection.
CA-125 is a tumour marker produced primarily by epithelial ovarian cancer cells, but also raised in many benign conditions — endometriosis, fibroids, pelvic inflammatory disease, menstruation, pregnancy, and ascites. It is most useful for monitoring known ovarian cancer and as part of a workup for an adnexal mass alongside ultrasound. Not recommended as a stand-alone screening test in average-risk women.
Most useful when an ovarian / adnexal mass is detected on ultrasound
Falls with effective treatment; rise during follow-up may signal recurrence
Combined with ultrasound and menopausal status (RMI score) to estimate cancer probability
Often raised in benign gynaecological conditions — context is essential
Mesothelioma, peritoneal carcinomatosis, ascites of any cause
Used in surveillance protocols alongside transvaginal ultrasound
Standard adjunct to refine cancer risk before surgery
Periodic CA-125 to detect early recurrence
Periodic surveillance alongside transvaginal USG
Persistent bloating, pelvic pain, urinary frequency, early satiety
Multiple first-degree relatives with ovarian or breast cancer
Sometimes used alongside imaging — interpreted with caution
Higher cancer risk in this group — CA-125 is more discriminating after menopause
Combined with imaging and other markers in workup
| Parameter | What It Measures | Reference Range |
|---|---|---|
| Normal Upper Limit | Adult women | < 35 U/mL |
| Mild Elevation | Often benign causes | 35–100 U/mL |
| Marked Elevation | Higher concern in postmenopausal women | > 200 U/mL |
| RMI Score | Risk of Malignancy Index — combines USG, menopause, CA-125 | > 200 = surgical referral |
| Trend in Treatment | Nadir + rising trend signals recurrence | Compare to baseline |
CA-125 below 35 U/mL with normal pelvic imaging is reassuring. Continue routine yearly screening if you have risk factors.
Mild rises are very often benign — endometriosis, fibroids, menstruation, pregnancy, PID. In postmenopausal women with a pelvic mass, marked elevation needs urgent gynaecological review. Your physician will correlate with symptoms and history.
Every report is reviewed by an experienced pathologist with clear interpretation and clinical comment.
If further evaluation is needed — Pelvic / Transvaginal USG, HE4, CT/MRI Pelvis, CA 19-9, CEA, BRCA Testing — all available at the Goregaon West centre.
Our Goregaon West centre is on S V Road, easily accessible by train, bus, and auto from all parts of the western suburbs. We provide CA-125 Test and other pathology services to patients from the following nearby areas:
Trained phlebotomist visits with sterile kit at your convenience. Same-day report via email & WhatsApp.
Visit any of our 3 centres for CA-125 Test and other diagnostic services — walk-ins welcome
Practical answers about preparation, ranges, and booking